近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
1. Shu Chen, Zi Zhou, Fei-Xue Wei, Shou-Jie Huang, Zhong Tan, Ya Fang, Feng-Cai Zhu, Ting Wu,Jun Zhang, Ning-Shao Xia. Modeling the long-term antibody response of ahepatitis E vaccine [J]. Vaccine, 2015. (IF:3.624) 2. Ting Wu, Yue-Mei Hu, Juan Li, Kai Chu, Shou-Jie Huang, Hui Zhao, Zhong-Ze Wang, Chang-Lin Yang, Han-MinJiang, Yi-Jun Wang, Zhi-Jie Lin, Hui-Rong Pan, Wei Sheng, Fei-Xue Wei, Shao-WeiLi, Ying Wang, Feng-Cai Zhu, Chang-Gui Li, Jun Zhang, Ning-Shao Xia.Immunogenicity and safety of an E. coli–produced bivalent human papillomavirus(type 16 and 18) vaccine: a randomized controlled phase 2 clinical trial [J]. Vaccine,2015, 33: 3940-3946. (IF:3.624) 3. Jun Zhang, Xue-Feng Zhang, Shou-Jie Huang, Ting Wu, Yue-Mei Hu, Zhong-Ze Wang, HuaWang, Han-Min Jiang, Yi-Jun Wang, Qiang Yan, Meng Guo, Xiao-Hui Liu, Jing-XinLi, Chang-Lin Yang, Quan Tang, Ren-Jie Jiang, Hui-Rong Pan, Yi-Min Li, J.Wai-Kuo Shih, Mun-Hon Ng, Feng-Cai Zhu, Ning-Shao Xia. Long-term efficacy of ahepatitis E vaccine [J]. New England Journal of Medicine,2015, 372(10): 914-922. (IF: 55.873) 4. Shou-Jie Huang, Xiao-Hui Liu, Jun Zhang,Mun-Hon Ng. Protective immunity against HEV [J]. Current opinion in virology,2014, 5: 1-6. (IF: 6.298) 5. Feng-Cai Zhu, Shou-JieHuang, Ting Wu, Xue-Feng Zhang, Zhong-Ze Wang, Xing Ai, Qiang Yan, Chang-LinYang, Jia-Ping Cai, Han-Min Jiang, Yi-Jun Wang, Mun-Hon Ng, Jun Zhang, Ning-ShaoXia. Epidemiology of Zoonotic Hepatitis E: A Community-Based Surveillance Studyin a Rural Population in China [J]. PloS one, 2014, 9(1): e87154. (IF: 3.234,Co-First Author) 6. Hui Zhao, Zhi-Jie Lin, Shou-JieHuang, Juan Li, Xiao-Hui Liu, Meng Guo, Jun Zhang, Ning-Shao Xia,Hui-Rong Pan, Ting Wu, Chang-Gui Li. Correlation between ELISA andpseudovirion-based neutralisation assay for detecting antibodies against humanpapillomavirus acquired by natural infection or by vaccination [J]. HumanVaccines &Immunotherapeutics, 2014, 10(3): 740-746. (IF: 2.366) 7. Yuemei Hu, Shou-JieHuang, Kai Chu, Ting Wu, Zhong-Ze Wang, Chang-Lin Yang, Jia-Ping Cai,Han-Min Jiang, Yi-Jun Wang, Meng Guo, Xiao-Hui Liu, Hong-Jiang Huang, Feng-CaiZhu, Jun Zhang, Ning-Shao Xia. Safety of an Escherichia coli-expressed bivalenthuman papillomavirus (types 16 and 18) L1 virus-like particle vaccine: Anopen-label phase I clinical trial [J]. Human vaccines & immunotherapeutics,2014, 10(2): 469-475. (IF: 2.366, Co-FirstAuthor) 8. J. Zhang, X.-F. Zhang, C. Zhou, Z.-Z. Wang, S.-J. Huang, X. Yao, Z.-L. Liang,T. Wu, J.-X. Li, Q. Yan, C.-L. Yang, H.-M. Jiang, H.-J. Huang, Y.-L. Xian, J.W.-K. Shih, M.-H. Ng, Y.-M. Li, J.-Z. Wang, F.-C. Zhu, N.-S. Xia. Protectionagainst hepatitis E virus infection by naturally acquired and vaccine-inducedimmunity [J]. Clinical Microbiology and Infection, 2014, 20(6): O397-O405.(IF: 5.768) 9. Ting Wu, Shou-JieHuang, Feng-Cai Zhu, Xue-Feng Zhang, Xing Ai, Qiang Yan, Zhong-Ze Wang,Chang-Lin Yang, Han-Min Jiang, Xiao-Hui Liu, Meng Guo, Hai-Lian Du, Mun-Hon Ng,Jun Zhang, Ningshao Xia. Immunogenicity and safety of hepatitis E vaccine inhealthy hepatitis B surface antigen positive adults [J]. Human Vaccines &Immunotherapeutics, 2013, 9(11): 2474-2479. (IF: 2.131) 10. Ting Wu, Feng-Cai Zhu, Shou-JieHuang, Xue-Feng Zhang, Zhong-Ze Wang, Jun Zhang, Ning-Shao Xia. Safetyof hepatitis E vaccine for pregnant women: a preliminary analysis [J]. Hepatology,2012, 55(6): 2038-2038. (IF: 12.003) 11. Shoujie Huang, Xuefeng Zhang, HanminJiang, Qiang Yan, Xing Ai, Yijun Wang, Jiaping Cai, Lang Jiang, Ting Wu, ZhongzeWang, Li Guan, J. Wai Kuo Shih, Mun-Hon Ng, Fengcai Zhu, Jun Zhang, NingshaoXia. Profile of acute infectious markers in sporadic hepatitis E[J].PloSone, 2010, 5(10): e13560. (IF:4.411, Co-First Author) 12. Feng-Cai Zhu, Jun Zhang, Xue-Feng Zhang, Cheng Zhou, Zhong-ZeWang, Shou-Jie Huang, HuaWang, Chang-Lin Yang, Han-Min Jiang, Jia-Ping Cai, Yi-Jun Wang, Xing Ai,Yue-Mei Hu, Quan Tang, Xin Yao, Qiang Yan, Yang-Ling Xian, Ting Wu, Yi-Min Li, JiMiao, Mun-Hon Ng, James Wai-Kuo Shih, Ning-Shao Xia. Efficacy and safety of arecombinant hepatitis E vaccine in healthy adults: a large-scale, randomised,double-blind placebo-controlled, phase 3 trial [J]. The Lancet, 2010,376(9744): 895-902. (IF:33.633)
京公网安备 11010802027423号